11β-hydroxylase deficiency differential diagnosis: Difference between revisions
No edit summary |
|||
Line 6: | Line 6: | ||
11β-hydroxylase deficiency must be differentiated from diseases that cause [[ambiguous genitalia]] such as [[21-hydroxylase deficiency]], [[17 alpha-hydroxylase deficiency]], [[3 beta-hydroxysteroid dehydrogenase deficiency]] and Gestational [[hyperandrogenism]]. | 11β-hydroxylase deficiency must be differentiated from diseases that cause [[ambiguous genitalia]] such as [[21-hydroxylase deficiency]], [[17 alpha-hydroxylase deficiency]], [[3 beta-hydroxysteroid dehydrogenase deficiency]] and Gestational [[hyperandrogenism]]. | ||
==11β-hydroxylase deficiency== | ==Differentiating 11β-hydroxylase deficiency from other diseases== | ||
[[Congenital adrenal hyperplasia]] due to 11-hydroxylase deficiency must be differentiated from diseases that cause [[ambiguous genitalia]]:<ref name="pmid17875484">{{cite journal |vauthors=Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT |title=Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development |journal=Best Pract. Res. Clin. Endocrinol. Metab. |volume=21 |issue=3 |pages=351–65 |year=2007 |pmid=17875484 |doi=10.1016/j.beem.2007.06.003 |url=}}</ref><ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref> | |||
{| class="wikitable" | {| class="wikitable" | ||
!Disease name | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | ||
! colspan="2" | | ! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Steroid status | ||
!Important clinical findings | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Important clinical findings | ||
|- | |- | ||
! | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Increased | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Decreased | |||
!Decreased | |||
|- | |- | ||
|[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]] | |[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]] | ||
Line 28: | Line 26: | ||
* [[Aldosterone]] | * [[Aldosterone]] | ||
* [[Corticosterone]] (salt-wasting) | * [[Corticosterone]] (salt-wasting) | ||
* [[Cortisol]] ( | * [[Cortisol]] ([[virilization]]) | ||
| | | | ||
* [[Ambiguous genitalia]] in female | * [[Ambiguous genitalia]] in female | ||
Line 39: | Line 37: | ||
* [[Deoxycorticosterone]] | * [[Deoxycorticosterone]] | ||
* 11-Deoxy-[[cortisol]] | * 11-Deoxy-[[cortisol]] | ||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] (mild elevation) | ||
| | | | ||
* [[Cortisol]] | * [[Cortisol]] | ||
Line 79: | Line 77: | ||
* 46-XY infants often show [[undervirilization]], due to a block in [[testosterone]] synthesis | * 46-XY infants often show [[undervirilization]], due to a block in [[testosterone]] synthesis | ||
|- | |- | ||
|Gestational [[hyperandrogenism]] | | Gestational [[hyperandrogenism]] | ||
| colspan="2" | | | colspan="2" | | ||
* Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | * Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high | ||
* If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | * If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]] | ||
| | | | ||
* [[Androgen]] excess | * [[Androgen]] excess in mother | ||
* History of [[androgen]] containing [[medication]] consumption during [[pregnancy]] in mother | * History of [[androgen]] containing [[medication]] consumption during [[pregnancy]] in mother | ||
* [[Virilization]] in a 46,XX individual with normal female internal anatomy | * [[Virilization]] in a 46,XX individual with normal female internal anatomy | ||
Line 90: | Line 88: | ||
|} | |} | ||
11β-hydroxylase deficiency must be differentiated from diseases that cause [[virilization]] and [[hirsutism]] in female:<ref name="pmid24830586">{{cite journal |vauthors=Hohl A, Ronsoni MF, Oliveira Md |title=Hirsutism: diagnosis and treatment |journal=Arq Bras Endocrinol Metabol |volume=58 |issue=2 |pages=97–107 |year=2014 |pmid=24830586 |doi= |url=}}</ref><ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref><ref name="ISBN:978-0323297387">{{cite book | last = Melmed | first = Shlomo | title = Williams textbook of endocrinology | publisher = Elsevier | location = Philadelphia, PA | year = 2016 | isbn = 978-0323297387 }}=</ref> | |||
{| class="wikitable" | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Steroid status | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other laboratory | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Important clinical findings | |||
|- | |||
|Non-classic type of [[21-hydroxylase deficiency]] | |||
|Increased: | |||
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | |||
* Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] in response to [[ACTH]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* No symptoms in infancy and male | |||
* [[Virilization]] in females | |||
|- | |||
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | |||
|Increased: | |||
* DOC | |||
* 11-Deoxy-[[Cortisol]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Hypertension]] and [[hypokalemia]] | |||
* [[Virilization]] | |||
|- | |||
|[[3 beta-hydroxysteroid dehydrogenase deficiency]] | |||
|Increased: | |||
* [[DHEA]] | |||
* [[17-hydroxypregnenolone]] | |||
* [[Pregnenolone]] | |||
Decreased: | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* Salt-wasting [[adrenal crisis]] in infancy | |||
* Mild [[virilization]] of genetically female infants | |||
* [[Undervirilization]] of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes. | |||
|- | |||
|[[Polycystic ovary syndrome ]] | |||
| | |||
* High [[DHEAS]] and [[androstenedione]] levels | |||
| | |||
* Low [[testosterone]] levels | |||
| | |||
* [[Polycystic ovaries]] in sonography | |||
* [[Obesity]] | |||
* [[PCOS]] is the most common cause of [[hirsutism]] in women | |||
* No evidence another diagnosis | |||
|- | |||
|[[Adrenal tumors]] | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* Low [[testosterone]] level | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
|Ovarian [[virilizing]] tumor | |||
| | |||
* Variable levels depends on [[tumor]] type | |||
| | |||
* [[Testosterone]] is high | |||
| | |||
* Older age | |||
* Rapidly progressive symptoms | |||
|- | |||
|[[Cushing's syndrome]] | |||
| | |||
* Increase [[cortisol]] & metabolites | |||
* Variable other [[steroids]] | |||
| | |||
* Variable [[mineralocorticoid]] excess | |||
| | |||
* [[Cushingoid appearance]] | |||
|- | |||
|[[Hyperprolactinemia]] | |||
| | |||
* Normal levels of most of [[steroids]] | |||
| | |||
* Increased [[prolactin]] | |||
| | |||
* [[Infertility]], [[galactorrhea]] | |||
|} | |||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 18:12, 28 August 2017
11β-hydroxylase deficiency Microchapters |
Differentiating 11β-hydroxylase deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
11β-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 11β-hydroxylase deficiency differential diagnosis |
11β-hydroxylase deficiency differential diagnosis in the news |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
Risk calculators and risk factors for 11β-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
11β-hydroxylase deficiency must be differentiated from diseases that cause ambiguous genitalia such as 21-hydroxylase deficiency, 17 alpha-hydroxylase deficiency, 3 beta-hydroxysteroid dehydrogenase deficiency and Gestational hyperandrogenism.
Differentiating 11β-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 11-hydroxylase deficiency must be differentiated from diseases that cause ambiguous genitalia:[1][2]
Disease name | Steroid status | Important clinical findings | |
---|---|---|---|
Increased | Decreased | ||
Classic type of 21-hydroxylase deficiency |
|
| |
11-β hydroxylase deficiency |
|
| |
17-α hydroxylase deficiency |
| ||
3 beta-hydroxysteroid dehydrogenase deficiency |
| ||
Gestational hyperandrogenism |
|
|
11β-hydroxylase deficiency must be differentiated from diseases that cause virilization and hirsutism in female:[3][2][4]
Disease name | Steroid status | Other laboratory | Important clinical findings |
---|---|---|---|
Non-classic type of 21-hydroxylase deficiency | Increased:
|
|
|
11-β hydroxylase deficiency | Increased:
Decreased: |
|
|
3 beta-hydroxysteroid dehydrogenase deficiency | Increased:
Decreased: |
|
|
Polycystic ovary syndrome |
|
|
|
Adrenal tumors |
|
|
|
Ovarian virilizing tumor |
|
|
|
Cushing's syndrome |
|
||
Hyperprolactinemia |
|
|
References
- ↑ Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007). "Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 351–65. doi:10.1016/j.beem.2007.06.003. PMID 17875484.
- ↑ 2.0 2.1 White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Hohl A, Ronsoni MF, Oliveira M (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586. Vancouver style error: initials (help)
- ↑ Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=